RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Cogent Biosciences, Inc. COGT |
RA CAPITAL MANAGEMENT L.P. | 0 0.000% |
-5,999,481 (Position Closed) |
Filing |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
RA CAPITAL MANAGEMENT L.P. | 5,999,481 8.600% |
2,387,274 (+66.09%) |
Filing |
| 2022-09-26 4:37 pm Purchase |
2022-09-15 | 13G | Cogent Biosciences, Inc. COGT |
RA CAPITAL MANAGEMENT L.P. | 3,588,081 6.090% |
3,588,081 (New Position) |
Filing |
| 2022-09-06 4:30 pm Purchase |
2022-08-24 | 13G | Cogent Biosciences, Inc. COGT |
RA CAPITAL MANAGEMENT L.P. | 3,612,207 5.490% |
3,612,207 (New Position) |
Filing |